The main objective is to assist practitioners in managing men and women diagnosed with Trichomonas vaginalis (TV) infection. This guideline offers recommendations on the diagnostic tests, treatment regimens and health promotion principles needed for the effective management of TV, covering the management of the initial presentation, as well as how to prevent transmission and future infection.
Wolner-HanssenPKreigerJNStevensCE. Clinical manifestations of vaginal trichomoniasis. JAMA1989; 264: 571–576.
2.
FoutsACKrausSJ. Trichomonas vaginalis: re-evaluation of its clinical presentation and laboratory diagnosis. J Infect Dis1980; 141: 137–143.
3.
HollmanDCoupeySMFoxAS. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J Pediatr Adolesc Gynecol2010; 23: 312–316.
4.
KreigerJNJennyCVerdonM. Clinical manifestations of trichomoniasis in men. Ann lntern Med1993; 118: 844–849.
5.
NicolCSWestonTET. Natural history of trichomonal infection in males. Brit J Vener Dis1963; 39: 251–251.
6.
SeñaAC. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis2010; 51: 114–115.
7.
SaurinaGRMcCormackWM. Trichomoniasis in pregnancy. Sex Trans Dis1997; 24: 361–362.
8.
CotchMFPastorekJGNugentRP. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Trans Dis1997; 24: 353–360.
9.
MannJRMcDermottSBarnesTL. Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol2009; 19: 891–899.
10.
SebitloaneHMMoodleyJEsterhuizenTM. Pathogenic lower genital tract organisms in HIV-infected and uninfected women, and their association with postpartum infectious morbidity. S Afr Med J2011; 101: 466–469.
11.
KlebanoffMACareyJCHauthJC. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Eng J Med2001; 345: 487–93.
12.
AndrewsWWSibaiBMThomEA. Randomised controlled trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol2003; 101: 847–55.
13.
KigoziGGBrahmbhattHWabwire-MangenF. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a sub analysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol2003; 189: 1398–1400.
14.
StringerEReadJSHoffmanI. Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J2010; 100: 58–64.
15.
SorvilloFKernottP. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet1998; 351: 213–214.
16.
LagaMManokaAKivuvuM. Non ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS1993; 7: 95–102.
17.
McClellandRS. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis2007; 195: 698–702.
18.
TantonC. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One2011; 6: e17480–e17480.
19.
MavedzengeSN. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis2010; 37: 460–466.
20.
BickleyLSKrisherKKPunsalangA. Comparison of direct fluorescent antibody, acridine orange, wet mount and culture for detection of Trichomonas vaginalis in women attending a public sexually transmitted disease clinic. Sex Trans Dis1989; 16: 127–131.
21.
KreigerJNTamMRStevensCE. Diagnosis of Trichomoniasis: comparison of conventional wet-mount examination with cytological studies, cultures, and monoclonal antibody staining of direct specimens. JAMA1988; 259: 1223–1227.
22.
CrucittiTVan DyckETeheA. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected swab specimens. Sex Transm Infect2003; 79: 393–398.
23.
TabriziSNPatersonBFairleyCK. A self administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis1997; 176: 289–292.
24.
KreigerJNViridansMSiegelN. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis1992; 166: 1362–1366.
25.
KingstonMABansalDCarlinEM. ‘Shelf life' of Trichomonas vaginalis. Int J STD AIDS2003; 14: 28–29.
26.
Van Der PolBKraftCSWilliamsJA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol2006; 44: 366–373.
27.
HuppertJS. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis2007; 45: 194–198.
28.
HuppertJS. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol2005; 43: 684–687.
29.
NyeMBSchwebkeJRBodyBA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol2009; 200: 188.e181–188.e187.
30.
HobbsMM. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol2006; 44: 3994–3999.
31.
Van Der SheeCvan BelkumAZwiggersL. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount, culture and fluorescent staining. J Clin Microbiol1999; 37: 4127–4130.
32.
RadonjicIVDzamicAMMitrovicSM. Diagnosis of Trichomonas vaginalis: the sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reproduc Biol2006; 126: 116–120.
33.
Adu-SarkodiY. Comparison of latex agglutination, wet preparation, and culture for the detection of Trichomonas vaginalis. Sex Transm Infect2004; 80: 201–203.
34.
HegazyMMEl-TantawyNLSolimanMM. Performance of rapid immunochromatographic assay in the diagnosis of Trichomoniasis vaginalis. Diagn Microbiol Infect Dis2012; 74: 49–53.
35.
CampbellLWoodsVLloydT. Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection. J Clin Microbiol2008; 46: 3467–3469.
36.
SchmidGPMathenyLCZaidiAA. Evaluation of six media for the growth of Trichomonas vaginalis from vaginal secretions. J Clin Microbiol1989; 27: 1230–1233.
37.
BorchardtKA. A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis. Genitourin Med1997; 73: 297–298.
38.
el NagaIFKhalifaAMel AzzouniMZ. In-pouch TV culture system in diagnosis of Trichomonas vaginalis infection. J Egyptian Soc Parasitol2001; 31: 647–656.
39.
LeviMH. Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis. J Clin Microbiol1997; 35: 3308–3310.
40.
SmithKS. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas. Int J STD AIDS2005; 16: 811–815.
41.
WendelKA. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect2003; 79: 151–153.
42.
Kaydos-DanielsSC. Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol2003; 41: 318–323.
43.
SchwebkeJRLawingLF. Improved detection by DNA amplification of Trichomonas vaginalis in males. J Clin Microbiol2002; 40: 3681–3683.
44.
KaydosSC. Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol2002; 40: 89–95.
45.
JordanJALoweryDTruccoM. TaqMan-based detection of Trichomonas vaginalis DNA from female genital specimens. J Clin Microbiol2001; 39: 3819–3822.
46.
LawingLFHedgesSRSchwebkeJR. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol2000; 38: 3585–3588.
47.
CrucittiT. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens. Sex Transm Infect2003; 79: 393–398.
48.
PillayA. Comparison of a TaqMan-based real-time polymerase chain reaction with conventional tests for the detection of Trichomonas vaginalis. Sex Transm Infect2007; 83: 126–129.
SimpsonP. Real-time PCRs for detection of Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens. J Med Microbiol2007; 56: 772–777.
51.
Shipitsyna, et al. Evaluation of polymerase chain reaction assays for the diagnosis of Trichomonas vaginalis infection in Russia. J Eur Acad Dermatol Venereol Epub ahead of print 12 June 2012. DOI: 10.1111/j.1468-3083.2012.04593.x.
52.
HardickA. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J Clin Microbiol2006; 44: 4197–4199.
53.
MunsonE. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J Clin Microbiol2008; 46: 3368–3374.
54.
CosentinoLACampbellTJettA. Use of nucleic acid amplification testing or diagnosis of anorectal sexually transmitted infections. J Clin Microbiol2012; 50: 2005–2008.
55.
SchwebkeJRHobbsMMTaylorSN. Molecular testing for Trichomonas vaginalis in women: results from a prospective US Clinical trial. J Clin Microbiol2011; 49: 4106–4111.
56.
GinocchioCCChapinKSmithJS. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol2012; 50: 2601–2608.
57.
FornaFGülmezogluAM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev2003; 2: CD000218–CD000218.
58.
HagerDBrownSTKrausSJ. Metronidazole for vaginal trichomoniasis seven day vs single-dose regimens. JAMA1980; 244: 1219–1220.
59.
ThinRNSymondsMAEBookerR. Double-blind comparison of a single dose and a five-day course of metronidazole in the treatment of trichomoniasis. Brit J Vener Disl979; 55: 354–356.
60.
GülmezogluAMAzharM. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev20115CD000220–CD000220.
61.
BurtinPTaddioAAdburnuO. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol1995; 172: 525–529.
62.
CzeizelAERockenbauerM. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol1998; 105: 322–327.
63.
Caro-PatonTCarvajalAde diegoIM. Is metronidazole teratogenic: a meta–analysis. Br J Clin Pharmacol1997; 44: 179–182.
64.
KissingerPMenaLLevisonJ. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr2010; 55: 565–571.
PearlmanMDYasharCErnstS. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol1996; 174: 934–936.
WHO 2006. Guidelines on Co-trimoxazole Prophylaxis for HIV related infections among children, adolescents and adults. Recommendations for a public health approach. WHO Guidelines, pp.24–25.
69.
HelmsDJMosureDJSecorWE. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol2008; 198: 370.e1–370.e7.
70.
KissingerPSecorWELeichliterJS. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. CID2008; 46: 994–999.
71.
KirkcaldyRDAugostiniPAsbelLE. Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010. Emerg Infect Dis2012; 18: 939–943.
72.
BossermanEAHelmsDJMosureDJ. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis2011; 38: 983–987.
73.
DasSHuengsbergMShahmaneshM. Treatment failure of vaginal trichomoniasis in clinical practice. Int J STD AIDS2005; 16: 284–286.
74.
SchwebkeJRBarrientesFJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother2006; 50: 4209–4210.
75.
Crowell AL, Sanders-Lewis KA and Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 2003; 47: 1407–1409.
76.
MattilaJMannistoPTMantylaR. Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother1983; 23: 721–725.
Mammen-TobinAWilsonJD. Management of metronidazole-resistant Trichomonas vaginalis – a new approach. Intl J STD AIDS2005; 16: 488–490.
80.
NyirjesyPSobelJDWeitzMV. Difficult to treat trichomoniasis: results with paromomycin cream. Clin Infect Dis1998; 26: 986–988.
81.
GoldmanLMUpcroftJAWorkowskiK. Treatment of metronidazole-resistant Trichomonas vaginalis. Sexual Health2009; 6: 345–347.
82.
LyngJChristensenJ. A double blind study of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand1981; 60: 199–201.
83.
DykersJR. Single dose metronidazole treatment for trichomonal vaginitis – patient and consort. N Eng J Med1975; 293: 23–24.
84.
SchwebkeJRDesmondRA. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis2010; 37: 392–396.
85.
KreigerJNVerdonMSiegelN. Natural history of urogenital trichomoniasis in men. J Urol1993; 149: 1455–1458.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
